ArticleAnnals of hematology2021

Successful treatment with enasidenib, bortezomib, and dexamethasone for the synchronous occurrence of IDH2-positive acute myeloid leukemia and multiple myeloma.

Donald C Moore et al.PubMed ↗Publisher ↗

No numbers read from the abstract.